Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2018

Nov 14, 2018

34129_dirs_2018-11-14_03e9b42c-587f-41e2-b3f4-bdc544039482.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2018-11-13

Reporting Person: Koenig Scott (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-11-13 Common Stock M 40000 $0.94 Acquired 173163 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-11-13 Employee stock option (right to buy) $0.94 M 40000 Disposed 2019-01-10 Common Stock (40000.0) Direct

Footnotes

F1: The transaction represents an exercise and hold of expiring options.